Can adiponectin be a novel metabolic biomarker for heart failure?

Circulation Journal

Volumn 73, Issue 6, 2009, Pages 1012-1013

  Okamoto, Hiroshi ^a  

^a HOKKAIDO CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; NITRIC OXIDE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BODY MASS; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; DRUG MECHANISM; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HUMAN; KNOCKOUT MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; OXIDATIVE STRESS; TREATMENT DURATION;

ADIPONECTIN; BIOLOGICAL MARKERS; CHRONIC DISEASE; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649844003     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0235     Document Type: Editorial

References (10)

1. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756-1762. (Pubitemid 41372115)
2. Nakamura T, Funayama H, Kubo N, Yasu T, Kawakami M, Saito M, et al. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 2006; 70: 1557-1562. (Pubitemid 44819870)
3. Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, et al. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 2007; 71: 623-630.
4. Shibata R, Numaguchi Y, Matsushita K, Sone T, Kubota R, Ohashi T, et al. Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction. Am J Cardiol 2008; 101: 1712-1715.
5. Ingelsson E, Risérus U, Berne C, Frystyk J, Flyvbjerg A, Axelsson T, et al. Adiponectin and risk of congestive heart failure. JAMA 2006; 295: 1772-1774.
6. Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ, et al. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 2009; 53: 754-762.
7. Yamaji M, Tsutamoto T, Tanaka T, Kawahara C, Nishiyama K, Yamamoto T, et al. Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure. Circ J 2009; 73: 1067-1073.
8. Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 2007; 115: 1408-1416. (Pubitemid 46648376)
9. Chen H, Montagnard M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45021-45026. (Pubitemid 37377262)
10. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007; 42: 1065-1074. (Pubitemid 46829193)